LOPETUSO, LORIS RICCARDO
 Distribuzione geografica
Continente #
AS - Asia 760
NA - Nord America 466
EU - Europa 364
SA - Sud America 175
AF - Africa 16
OC - Oceania 3
Totale 1.784
Nazione #
US - Stati Uniti d'America 418
BD - Bangladesh 265
IT - Italia 176
BR - Brasile 130
SG - Singapore 119
CN - Cina 117
VN - Vietnam 104
DE - Germania 99
HK - Hong Kong 82
FR - Francia 36
KR - Corea 28
CA - Canada 25
AR - Argentina 18
MX - Messico 15
EC - Ecuador 14
GB - Regno Unito 13
ID - Indonesia 11
IN - India 11
PL - Polonia 11
NL - Olanda 9
CO - Colombia 4
PK - Pakistan 4
RU - Federazione Russa 4
AU - Australia 3
MA - Marocco 3
PE - Perù 3
SN - Senegal 3
UA - Ucraina 3
UY - Uruguay 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
IQ - Iraq 2
JP - Giappone 2
RO - Romania 2
SA - Arabia Saudita 2
TR - Turchia 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AL - Albania 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
FI - Finlandia 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LT - Lituania 1
MD - Moldavia 1
MT - Malta 1
MZ - Mozambico 1
NG - Nigeria 1
NP - Nepal 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 1.784
Città #
San Jose 106
Frankfurt am Main 94
Hong Kong 82
New York 58
Ashburn 55
Singapore 47
Beijing 37
Ho Chi Minh City 37
Hanoi 30
Seoul 27
Rome 23
Milan 19
Los Angeles 18
Dallas 13
Buffalo 12
Chicago 12
Naples 11
Toronto 11
Mexico City 10
Hillsboro 9
São Paulo 9
Warsaw 9
Florence 7
Guayaquil 6
Santa Clara 6
Brasília 5
Padua 5
Philadelphia 5
Biên Hòa 4
Bắc Ninh 4
Campinas 4
Porto Alegre 4
Rio de Janeiro 4
Seattle 4
Turin 4
Amsterdam 3
Bari 3
Bexley 3
Bologna 3
Boston 3
Da Nang 3
Dakar 3
Goiânia 3
Haiphong 3
London 3
Quito 3
Ribeirão Preto 3
Roubaix 3
Tashkent 3
Bahía Blanca 2
Bergamo 2
Bogotá 2
Brescia 2
Cagliari 2
Caxias do Sul 2
Charlotte 2
Council Bluffs 2
Fermo 2
Genoa 2
Guarulhos 2
Ha Long 2
Johannesburg 2
Joinville 2
Kyiv 2
La Joya de Los Sachas 2
Lahore 2
Leeds 2
Limburg an der Lahn 2
Manaus 2
Mendoza 2
Montevideo 2
Montreal 2
Newark 2
Palermo 2
Pittsburgh 2
Reston 2
Rio Grande 2
Riposto 2
Santiago 2
Sapiranga 2
Sete Lagoas 2
Sydney 2
Teófilo Otoni 2
Tokyo 2
Tây Ninh 2
Viamão 2
Abu Dhabi 1
Acerra 1
Afonso Cláudio 1
Afonso Cunha 1
Ajax 1
Albuquerque 1
Alegrete 1
Alta Floresta d'Oeste 1
Altinho 1
Ancol 1
Ankara 1
Aracaju 1
Araguaiana 1
Araraquara 1
Totale 921
Nome #
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 100
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 74
Escherichia coli nissle 1917 modulate gut microbiota composition in ulcerative colitis patients 57
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 55
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 52
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation 50
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 47
Resilience and Self-Care in Patients with Inflammatory Bowel Disease: A Multicentre Cross-Sectional Study in Outpatient Settings 47
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 44
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 43
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 40
Abdominal and Bowel Ultrasound Knowledge Among Young Gastroenterologists: Results of an Italian Survey 40
Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis 37
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 37
Bacillus clausii and gut homeostasis: state of the art and future perspectives 37
Psychopharmacological Therapy Positively Modulates Disease Activity in Inflammatory Bowel Disease: A Systematic Review 36
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 35
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 34
Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver 34
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 30
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 29
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study 29
A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis 27
European Crohn's and colitis organisation topical review on treatment withdrawal ['exit strategies'] in inflammatory bowel disease 25
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 24
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 24
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update 23
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 23
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 22
COVID-19 and intestinal inflammation: Role of fecal calprotectin 22
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease 22
Role of Helicobacter pylori infection on nutrition and metabolism 22
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 22
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 21
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus 21
Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19 20
Characterization of sarcopenia in an IBD population attending an Italian gastroenterology tertiary center 20
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists 19
Assessment of neurological manifestations in hospitalized patients with COVID‐19 19
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 18
Predicting In‐Hospital Mortality in COVID‐19 Older Patients with Specifically Developed Scores 17
Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients 16
Can we predict the efficacy of anti-TNF-α agents? 16
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 15
Bariatric procedures and microbiota: patient selection and outcome prediction 15
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 14
Beyond the HLA Genes in Gluten-Related Disorders 14
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 13
Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis 13
Gut microbiota and inflammatory bowel disease: So far so gut! 12
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 12
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 11
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 11
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 11
Bacteriocins and bacteriophages: Therapeutic weapons for gastrointestinal diseases? 11
Commentary to “safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease” 11
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 10
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 10
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 10
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn’s Disease: A Prospective Study 10
Proteobacteria: A common factor in human diseases 9
Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab 9
How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists 8
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach 8
Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study 8
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea 8
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 8
Future challenges in gastroenterology and hepatology, between innovations and unmet needs: A SIGE Young Editorial Board's perspective 8
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 7
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 7
The therapeutic management of gut barrier leaking: The emerging role for mucosal barrier protectors 7
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis 7
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory study 7
The use of probiotics in different phases of diverticular disease 7
Fecal transplantation for ulcerative colitis: current evidence and future applications 6
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises from a First Meta-Analysis 6
Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape 6
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 5
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools 5
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 5
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 5
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. Pylori infection 5
13C-octanoic acid breath test to study gastric emptying time 5
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 5
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 5
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 4
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 4
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 4
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 4
Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients 4
Evaluation of factors associated with trust in telemedicine in patients with inflammatory bowel disease during COVID-19 pandemic: a multicenter cross-sectional survey 4
The innate and adaptive immune system as targets for biologic therapies in inflammatory bowel disease 4
SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease 4
Intestinal permeability in physiological and pathological conditions: Major determinants and assessment modalities 4
Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1α and Microbiota's Crosstalk 3
Unfolded protein response: An essential element of intestinal homeostasis and a potential therapeutic target for inflammatory bowel disease 3
The interplay between gut microbiota and the unfolded protein response: Implications for intestinal homeostasis preservation and dysbiosis-related diseases 3
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 3
Driving scientific progress and shaping the future of gastroenterology: a new start for our Journal, between innovation, growth and multidisciplinarity 3
The impact of E-Cigarettes and Heat-Not-Burn Tobacco on Postoperative Recurrence of Crohn’s Disease: A Multicenter International Study 3
Totale 1.853
Categoria #
all - tutte 12.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.727


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202597 0 0 0 0 0 0 0 7 8 29 37 16
2025/20261.897 51 50 105 134 89 47 63 160 212 326 458 202
Totale 1.994